J
Jun Ma
Researcher at Harbin Institute of Technology
Publications - 1523
Citations - 58397
Jun Ma is an academic researcher from Harbin Institute of Technology. The author has contributed to research in topics: Nasopharyngeal carcinoma & Medicine. The author has an hindex of 97, co-authored 1338 publications receiving 39643 citations. Previous affiliations of Jun Ma include Shenyang Aerospace University & University of Technology, Sydney.
Papers
More filters
Journal ArticleDOI
MRI-detected skull-base invasion: prognostic value and therapeutic implication in intensity-modulated radiotherapy treatment for nasopharyngeal carcinoma.
Yi Kan Cheng,Li Zhi Liu,Ning Jiang,Dan Yue,Ling Long Tang,Fan Zhang,Li Lin,Xu Liu,Lei Chen,Jun Ma +9 more
TL;DR: In this paper, a classification of skull-base invasion in nasopharyngeal carcinoma (NPC) patients treated with intensity-modulated radiotherapy (IMRT) was presented.
Journal ArticleDOI
The bromate formation accompanied by the degradation of 2,4-bromophenol in UV/peroxymonosulfate
Congwei Luo,Jing Gao,Qiao Ma,Daoji Wu,Xiaoxiang Cheng,Jin Jiang,Weiwei Zhou,Zhichao Yang,Jun Ma +8 more
TL;DR: In this article, the degradation kinetics of 2,4-bromophenol and the fate of bromine affected by different water matrix (i.e., dissolved organic matter, chloride ions, and solution pH) were explored.
Journal ArticleDOI
Cigarette smoking complements the prognostic value of baseline plasma Epstein-Barr virus deoxyribonucleic acid in patients with nasopharyngeal carcinoma undergoing intensity-modulated radiation therapy: a large-scale retrospective cohort study.
Jia Wei Lv,Yu Pei Chen,Guan Qun Zhou,Ling Long Tang,Yan Ping Mao,Wen Fei Li,Rui Guo,Ai Hua Lin,Jun Ma,Ying Sun +9 more
TL;DR: Both cigarette smoking and baseline plasma EBV DNA were independent prognostic factors for survival outcomes and led to the refinement of the risks stratification for patient subsets, especially with improved risk discrimination in patients with high baseline plasmaEBV DNA.
Journal ArticleDOI
Delayed clinical complete response to intensity-modulated radiotherapy in nasopharyngeal carcinoma
TL;DR: Nearly half of the patients with partial response at 3-4 months achieve cCR by 6-9 months; delayed cCR is not a poor prognosticator, and later assessment of cCR at 6- 9 months after IMRT is acceptable in responding NPC.
Journal ArticleDOI
Study on the physicochemical properties of poly(methylmethacrylate) (PMMA) modified Pd/Fe nanocomposites: Roles of PMMA and PMMA/ethanol
TL;DR: In this article, the role of poly(methylmethacrylate) (PMMA) and PMMA/ethanol in controlling physicochemical properties of Pd/Fe nanoparticles (NPs) was investigated.